GlassScriptPhysician profile
John R Pollard
NPI 1932131265
$7,278.95
in general payments reported to CMS, 2019-2025
16 companies · $443 in 2025
The $443 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $112 · 2021: $173 · 2022: $266 · 2023: $5,753 · 2024: $316 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,554 · Food and Beverage: $1,336 · Travel and Lodging: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,554.00 |
| Food and Beverage | $1,336.17 |
| Travel and Lodging | $621.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $5,497.66 | 2022-2025 | Valtoco |
| Ucb, INC. | $711.23 | 2019-2025 | Fintepla, Briviact |
| Jazz Pharmaceuticals INC. | $286.55 | 2022-2024 | Epidiolex |
| Sk Life Science, INC. | $275.46 | 2021-2025 | Xcopri |
| Greenwich Biosciences, INC. | $179.26 | 2019-2021 | |
| Acadia Pharmaceuticals INC | $80.35 | 2023 | Daybue |
| Medtronic, INC. | $50.71 | 2025 | Percept PC Brainsense |
| Sumitomo Pharma America, INC. | $40.14 | 2023 | Aptiom |
| Livanova USA, INC. | $36.41 | 2024-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Sunovion Pharmaceuticals INC. | $28.07 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $19.57 | 2022 | |
| Supernus Pharmaceuticals, INC. | $15.96 | 2020 | |
| Biogen, INC. | $15.65 | 2019 | |
| Amgen INC. | $14.45 | 2019 | |
| Amneal Pharmaceuticals LLC | $13.88 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $13.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pollard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.